Skip to content

Clinical trials

Observational Pulmonary Arterial Hypertension trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Observational Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20112
20152
20161
20171
20182
20191
20202
20211
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Enrolling by invitation2
Recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Giessen4
Bayer3
Heidelberg University2
AOP Orphan Pharmaceuticals AG1
Actelion1
Pfizer1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Simon Jäger1
Technische Universität Dresden1
University Medicine Greifswald1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension17
Hypertension, Pulmonary11
Eisenmenger Complex1
Familial Primary Pulmonary Hypertension1
Lung Diseases1
Scleroderma, Systemic1
Vascular Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.